458 related articles for article (PubMed ID: 28271035)
1. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in
Shimazu-Kuwahara S; Harada N; Yamane S; Joo E; Sankoda A; Kieffer TJ; Inagaki N
Mol Metab; 2017 Mar; 6(3):288-294. PubMed ID: 28271035
[TBL] [Abstract][Full Text] [Related]
2. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions.
Nasteska D; Harada N; Suzuki K; Yamane S; Hamasaki A; Joo E; Iwasaki K; Shibue K; Harada T; Inagaki N
Diabetes; 2014 Jul; 63(7):2332-43. PubMed ID: 24584548
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Miyawaki K; Yamada Y; Ban N; Ihara Y; Tsukiyama K; Zhou H; Fujimoto S; Oku A; Tsuda K; Toyokuni S; Hiai H; Mizunoya W; Fushiki T; Holst JJ; Makino M; Tashita A; Kobara Y; Tsubamoto Y; Jinnouchi T; Jomori T; Seino Y
Nat Med; 2002 Jul; 8(7):738-42. PubMed ID: 12068290
[TBL] [Abstract][Full Text] [Related]
4. Diet-Induced Obese Mice and Leptin-Deficient
Lee E; Miedzybrodzka EL; Zhang X; Hatano R; Miyamoto J; Kimura I; Fujimoto K; Uematsu S; Rodriguez-Cuenca S; Vidal-Puig A; Gribble FM; Reimann F; Miki T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509948
[TBL] [Abstract][Full Text] [Related]
5. Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.
Maekawa R; Ogata H; Murase M; Harada N; Suzuki K; Joo E; Sankoda A; Iida A; Izumoto T; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Arima H; Hayashi Y; Seino Y
Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E572-E583. PubMed ID: 29406782
[TBL] [Abstract][Full Text] [Related]
6. Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient
D'souza AM; Johnson JD; Clee SM; Kieffer TJ
Mol Metab; 2016 Nov; 5(11):1103-1112. PubMed ID: 27818936
[TBL] [Abstract][Full Text] [Related]
7. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.
Gault VA; McClean PL; Cassidy RS; Irwin N; Flatt PR
Diabetologia; 2007 Aug; 50(8):1752-62. PubMed ID: 17558485
[TBL] [Abstract][Full Text] [Related]
8. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
[TBL] [Abstract][Full Text] [Related]
9. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.
Irwin N; McClean PL; O'Harte FP; Gault VA; Harriott P; Flatt PR
Diabetologia; 2007 Jul; 50(7):1532-40. PubMed ID: 17486314
[TBL] [Abstract][Full Text] [Related]
10. Absence of GIP secretion alleviates age-related obesity and insulin resistance.
Kanemaru Y; Harada N; Shimazu-Kuwahara S; Yamane S; Ikeguchi E; Murata Y; Kiyobayashi S; Hatoko T; Inagaki N
J Endocrinol; 2020 Apr; 245(1):13-20. PubMed ID: 31977316
[TBL] [Abstract][Full Text] [Related]
11. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
[TBL] [Abstract][Full Text] [Related]
12. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of fat-induced gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide secretion from K cells.
Yamane S; Harada N; Inagaki N
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):20-6. PubMed ID: 27186351
[TBL] [Abstract][Full Text] [Related]
14. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice.
Porter DW; Irwin N; Flatt PR; Hölscher C; Gault VA
Eur J Pharmacol; 2011 Jan; 650(2-3):688-93. PubMed ID: 21050845
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional factor Pdx1 is involved in age-related GIP hypersecretion in mice.
Ikeguchi E; Harada N; Kanemaru Y; Sankoda A; Yamane S; Iwasaki K; Imajo M; Murata Y; Suzuki K; Joo E; Inagaki N
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G272-G282. PubMed ID: 29723041
[TBL] [Abstract][Full Text] [Related]
16. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes.
Gault VA; Irwin N; Green BD; McCluskey JT; Greer B; Bailey CJ; Harriott P; O'harte FP; Flatt PR
Diabetes; 2005 Aug; 54(8):2436-46. PubMed ID: 16046312
[TBL] [Abstract][Full Text] [Related]
17. Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
Irwin N; Hunter K; Flatt PR
Peptides; 2008 Jun; 29(6):1036-41. PubMed ID: 18291559
[TBL] [Abstract][Full Text] [Related]
18. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
[TBL] [Abstract][Full Text] [Related]
19. Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
Irwin N; McClean PL; Patterson S; Hunter K; Flatt PR
Biol Chem; 2009 Jan; 390(1):75-80. PubMed ID: 18937625
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides.
Fukami A; Seino Y; Ozaki N; Yamamoto M; Sugiyama C; Sakamoto-Miura E; Himeno T; Takagishi Y; Tsunekawa S; Ali S; Drucker DJ; Murata Y; Seino Y; Oiso Y; Hayashi Y
Diabetes; 2013 Feb; 62(2):510-8. PubMed ID: 23099862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
